Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

Merrill, J. T., Guthridge, J., Smith, M., June, J., Koumpouras, F., Machua, W., Askanase, A., Khosroshahi, A., Sheikh, S. Z., Rathi, G., Burington, B., Foster, P., Matijevic, M., Arora, S., Wang, X., Gao, M., Wax, S., James, J. A., & Zack, D. J. (2023). Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial. Arthritis & Rheumatology, 75(12), 2185–2194. Portico. https://doi.org/10.1002/art.42652
Authors:
Joan T. Merrill
Joel Guthridge
Miles Smith
Joshua June
Fotios Koumpouras
Wambui Machua
Anca Askanase
Arezou Khosroshahi
Saira Z. Sheikh
Gaurav Rathi
Bart Burington
Paul Foster
Mark Matijevic
Sujata Arora
Xiaodong Wang
Minggeng Gao
Stephen Wax
Judith A. James
Debra J. Zack
Affiliated Authors:
Anca Askanase
Publication Type:
Article
Unique ID:
10.1002/art.42652
PMID:
Publication Date:
Data Source:
Scopus

Record Created: